Myriad Genetics Sees FY24 Gross Revenue $835M-$845M Vs $831M Estimate
Portfolio Pulse from Benzinga Newsdesk
Myriad Genetics has announced its FY24 gross revenue forecast to be between $835 million and $845 million, surpassing the previous estimate of $831 million.
August 06, 2024 | 9:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Myriad Genetics has provided a positive revenue forecast for FY24, projecting gross revenue between $835 million and $845 million, which is higher than the previous estimate of $831 million.
The higher-than-expected revenue forecast suggests strong business performance and potential growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100